aratinga.bio's Incubator/Accelerator Round

aratinga.bio raised a round of funding on June 14, 2017. Investors include Alexandria LaunchLabs.

aratinga.bio is a preclinical stage company developing novel immunotherapies to treat cancer. aratinga.bio is developing its proprietary platform to be effective against both hematological cancers and…

Articles about aratinga.bio's Incubator/Accelerator Round: